Back to top

genomics: Archive

Ekta Bagri

3 Top Genomics Stocks to Add to Your Portfolio in 2025

Investors interested in the Genomics and Synthetic Biology theme may consider adding these three stocks to their portfolio - Intellia Therapeutics (NTLA), uniQure (QURE) and Verve Therapeutics (VERV).

ILMNPositive Net Change BEAMPositive Net Change QUREPositive Net Change NTLANegative Net Change CRSPPositive Net Change VERVNo Net Change

Zacks Equity Research

REGN Signs $256M Buyout Deal With 23andMe to Boost Genomics Research

Regeneron is set to acquire 23andMe assets for $256 million to boost genetic drug discovery. The transaction is expected to close by third-quarter 2025.

REGNPositive Net Change BAYRYNegative Net Change HALONegative Net Change ALLONegative Net Change

Ekta Bagri

Promising Genomics & Synthetic Biology Stocks to Consider in 2025

Investors interested in the Genomics and Synthetic Biology theme should consider these stocks: Twist Bioscience Corporation, Wave Life Sciences, and CRISPR Therapeutics AG.

ILMNPositive Net Change BEAMPositive Net Change WVENegative Net Change NTLANegative Net Change CRSPPositive Net Change TWSTPositive Net Change